142 related articles for article (PubMed ID: 27353001)
21. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer.
Santa-Inez DC; Fuziwara CS; Saito KC; Kimura ET
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360757
[TBL] [Abstract][Full Text] [Related]
23. Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells.
Zhang HY; Wang HQ; Liu HM; Guan Y; Du ZX
Endocr Relat Cancer; 2008 Jun; 15(2):535-44. PubMed ID: 18430896
[TBL] [Abstract][Full Text] [Related]
24. Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1.
Wang J; Yang H; Si Y; Hu D; Yu Y; Zhang Y; Gao M; Zhang H
Cell Physiol Biochem; 2017; 43(4):1325-1336. PubMed ID: 28992617
[TBL] [Abstract][Full Text] [Related]
25. Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Anticancer Res; 2015 Dec; 35(12):6529-37. PubMed ID: 26637867
[TBL] [Abstract][Full Text] [Related]
26. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
Wu ZY; Wang SM; Chen ZH; Huv SX; Huang K; Huang BJ; Du JL; Huang CM; Peng L; Jian ZX; Zhao G
Cancer Biomark; 2015; 15(5):535-42. PubMed ID: 26406941
[TBL] [Abstract][Full Text] [Related]
27. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
[TBL] [Abstract][Full Text] [Related]
28. MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line.
Cheng Q; Zhang X; Xu X; Lu X
Ann Endocrinol (Paris); 2014 Sep; 75(4):187-93. PubMed ID: 25145559
[TBL] [Abstract][Full Text] [Related]
29. Expression of miR-100 and RBSP3 in FTC-133 cells after exposure to 131I.
Zhang S; Deng B; Zhang Y; Jiang N
Nucl Med Commun; 2014 Sep; 35(9):932-8. PubMed ID: 24785011
[TBL] [Abstract][Full Text] [Related]
30. miRNA expression in anaplastic thyroid carcinomas.
Hébrant A; Floor S; Saiselet M; Antoniou A; Desbuleux A; Snyers B; La C; de Saint Aubain N; Leteurtre E; Andry G; Maenhaut C
PLoS One; 2014; 9(8):e103871. PubMed ID: 25153510
[TBL] [Abstract][Full Text] [Related]
31. MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype.
Calabrese G; Dolcimascolo A; Torrisi F; Zappalà A; Gulino R; Parenti R
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544640
[TBL] [Abstract][Full Text] [Related]
32. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway.
Rahman MA; Salajegheh A; Smith RA; Lam AK
Exp Cell Res; 2015 Dec; 339(2):342-50. PubMed ID: 26384552
[TBL] [Abstract][Full Text] [Related]
34. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
Jiang C; Long J; Liu B; Xie X; Kuang M
Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA deregulation in human thyroid papillary carcinomas.
Pallante P; Visone R; Ferracin M; Ferraro A; Berlingieri MT; Troncone G; Chiappetta G; Liu CG; Santoro M; Negrini M; Croce CM; Fusco A
Endocr Relat Cancer; 2006 Jun; 13(2):497-508. PubMed ID: 16728577
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.
Xiao F; Chen J; Lian C; Han P; Zhang C
Mol Med Rep; 2015 Jan; 11(1):739-45. PubMed ID: 25335093
[TBL] [Abstract][Full Text] [Related]
38. Demethylation of TMS1 gene sensitizes thyroid cancer cells to TRAIL-induced apoptosis.
Siraj AK; Hussain AR; Al-Rasheed M; Ahmed M; Bavi P; Alsobhi SA; Al-Nuaim A; Uddin S; Al-Kuraya K
J Clin Endocrinol Metab; 2011 Jan; 96(1):E215-24. PubMed ID: 20926535
[TBL] [Abstract][Full Text] [Related]
39. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
Festa M; Petrella A; Alfano S; Parente L
Int J Cancer; 2009 Jun; 124(11):2728-36. PubMed ID: 19230027
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines.
Varmeh S; Vanden Borre P; Gunda V; Brauner E; Holm T; Wang Y; Sadreyev RI; Parangi S
Surgery; 2016 Jan; 159(1):152-62. PubMed ID: 26456124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
